Hoki Atsushi, Kurihara Shingo, Matsuda Yoshikazu
Department of Physical Therapy, Matsuda Orthopedic Clinic, Kumagaya, JPN.
Department of Orthopedic Surgery, Matsuda Orthopedic Clinic, Kumagaya, JPN.
Cureus. 2025 Aug 7;17(8):e89582. doi: 10.7759/cureus.89582. eCollection 2025 Aug.
The effect of supplementation of essential amino acids (EAAs) in knee osteoarthritis (OA) remains unclear. This study aimed to evaluate whether supplementation with EAA improves pain, patient-reported outcome measures, gait function, and quadriceps muscle volume in patients undergoing conservative treatment for knee OA.
A retrospective cohort study was conducted on outpatients undergoing physical therapy from April 2024 to March 2025. Inclusion criteria were patients who started physical therapy for knee OA, with exclusion of patients taking other supplements or having severe medical conditions. Patients who received EAA at the beginning of physical therapy were assigned to the EAA group (8 g/day supplementation), while those who did not were assigned to the control group. The primary outcome was the maximum value on the visual analogue scale (VAS). Secondary outcomes included the Knee injury and Osteoarthritis Outcome Score (KOOS) subscales, gait speed and steps, quadriceps torque, and quadriceps volume measured at baseline and 12 weeks.
Of the 51 patients initially included, 36 patients were ultimately analyzed (EAA group: n = 17, control group: n = 19). No significant differences were observed in VAS, KOOS subscales, and quadriceps torque between groups. However, the EAA group demonstrated significantly greater improvements in 6-meter gait speed, step count, and quadriceps volume compared to the control group. No adverse effects were observed associated with EAA supplementation.
EAA supplementation in the conservative treatment of knee OA demonstrated significant improvements in gait function and quadriceps muscle volume compared to the control group. These results suggest the efficacy of EAA supplementation in the conservative management of knee OA.
补充必需氨基酸(EAA)对膝骨关节炎(OA)的影响尚不清楚。本研究旨在评估补充EAA是否能改善接受膝OA保守治疗患者的疼痛、患者报告结局指标、步态功能和股四头肌体积。
对2024年4月至2025年3月接受物理治疗的门诊患者进行回顾性队列研究。纳入标准为开始接受膝OA物理治疗的患者,排除服用其他补充剂或患有严重疾病的患者。在物理治疗开始时接受EAA的患者被分配到EAA组(每天补充8克),而未接受的患者被分配到对照组。主要结局是视觉模拟量表(VAS)的最大值。次要结局包括在基线和12周时测量的膝关节损伤和骨关节炎结局评分(KOOS)子量表、步态速度和步数、股四头肌扭矩和股四头肌体积。
最初纳入的51例患者中,最终分析了36例患者(EAA组:n = 17,对照组:n = 19)。两组之间在VAS、KOOS子量表和股四头肌扭矩方面未观察到显著差异。然而,与对照组相比,EAA组在6米步态速度、步数和股四头肌体积方面的改善明显更大。未观察到与补充EAA相关的不良反应。
与对照组相比,补充EAA在膝OA保守治疗中显示出步态功能和股四头肌体积的显著改善。这些结果表明补充EAA在膝OA保守治疗中的有效性。